BJGBF yields 38461.54% · PFE yields 6.13%● Live data
📍 BJGBF pulled ahead of the other in Year 1
Combined, BJGBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BJGBF + PFE for your $10,000?
Beijing Gas Blue Sky Holdings Limited, an investment holding company, engages in the sale and distribution of natural gas and other related products in the People's Republic of China. It operates through Natural Gas Refuelling Station; Trading and Distribution of Natural Gas; Direct Supply to Industrial Users; and City Gas, Pipeline Construction Fee, Value-Added Service and Others segments. The company operates compressed natural gas (CNG) and liquefied natural gas (LNG) refueling stations for vehicles; and distributes and trades in CNG, LNG fuel oil and other related oil by-products as a wholesaler to industrial and commercial users through direct supply facilities. It also sells natural gas to residential, industrial, and commercial users through pipelines. In addition, the company is involved in the provision of repair and maintenance, and pipeline construction. The company owns 29 gas refueling stations, including 17 CNG refueling stations and 12 LNG refueling stations. The company was formerly known as Blue Sky Power Holdings Limited and changed its name to Beijing Gas Blue Sky Holdings Limited in January 2017. Beijing Gas Blue Sky Holdings Limited was founded in 2000 and is headquartered in Central, Hong Kong.
Full BJGBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.